Injective INJ
Current Price
$12.71 -0.44%
$0.8700 Daily Range (6.85%)
$12.17$13.04
$199.58M Daily Volume
1,691 BTC
Vol/MktCap: 16.03%
Market Performance
0.50% Relative BTC Volume
The total volume of Injective is $199.58M over the past 24 hours, compared to $40.28B total Bitcoin volume.
Hourly Moving Average
8 SMA $12.46 +1.99%
13 SMA $12.62 +0.74%
21 SMA $12.67 +0.28%
55 SMA $11.94 +6.43%
144 SMA $11.08 +14.70%
Price Performance
+2.68% 1 Hour Change
$12.71 from $12.38
+19.23% 7 Day Change
$2.44 from $10.27
+20.54% 14 Day Change
$2.61 from $10.10
-1.65% 30 Day Change
-$0.2101 from $12.92
All Time High
March 14, 2024
$52.62 -75.71%
-$39.84 vs. now
24H Change
-3.00M USD -0.24%
-25 BTC
Volume and Supply
Total Supply: 100.00M INJ 
97.73M INJ AvailableRelative Supply Ratio
4.76 x BTC Supply





Relative Trade Volume
15.83M INJ
traded over past 24 hours
Conversion Tool
Injective AI Market Analysis
The trading volume over the past 24 hours stands at approximately $213.33 million, which corresponds to a volume-to-market cap ratio of 17.22%. This level of trading activity suggests a healthy interest in the asset, although it is essential to note the volatility in the market.
Analyzing the hourly moving averages, the 8 SMA is at $12.46 with a positive change of 1.67%, while the 13 SMA is slightly above at $12.62, showing a modest increase of 0.42%. The 21 SMA, which aligns with the current price at $12.67, indicates stability, but the longer-term moving averages, such as the 55 SMA at $11.94 (+6.09%) and the 144 SMA at $11.08 (+14.34%), reflect a stronger bullish trend in the longer term.
In terms of momentum indicators, the 1-hour RSI is neutral at 49, suggesting no immediate overbought or oversold conditions. However, the 7-day RSI at 59 indicates that INJ is approaching overbought territory, supported by a significant 7-day price change of 17.1% and a notable 14-day price change of 20.9%.
Injective's current price is significantly below its all-time high of $52.62 reached in March 2024, indicating potential upside. Despite a slight decrease of 2.72% over the past 30 days, the positive trends in both short-term and long-term moving averages, coupled with strong volume, suggest a potential recovery phase.
Based on this analysis, a Buy rating is warranted as the asset shows signs of stability and positive momentum indicators, alongside healthy trading volume. The current price level presents a favorable entry point with potential for growth towards previous highs, making it an attractive opportunity for investors.
Updated 101 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
You May Also Like

LEO Token LEO
$9.06 +0.91%

Binance-Peg WETH WETH
$2,969.31 -1.04%

Bonk BONK
$0.00002205 -6.61%

Saros SAROS
$0.2523 +5.05%

Decentraland MANA
$0.3117 +0.13%

Reserve Rights RSR
$0.0079 -3.72%

EOS EOS
$0.5390 -2.03%

Binance-Peg BUSD BUSD
$0.9999 +0.02%
In The News

According to a Wednesday statement by SEC commissioner Hester ‘Crypto Mom’ Peirce, any firm eyeing tokenized securities must talk to regulators before moving forward.

The spot taker CVD data of the past three months showed that selling pressure from profit-taking activity was increasing in July.

In an announcement yesterday, Nasdaq-listed software company GameSquare Holdings revealed that it had purchased $5 million worth of Ethereum (ETH) as part of its $100 million ETH-f...

The first field deployment of Ripple’s US-dollar stablecoin, RLUSD, as a drought-insurance rail has wrapped up in Laikipia North, Kenya.